Nuzenio

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 20:15:49 GMTAmylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings - simplywall.st
Fri, 07 Aug 2026 15:53:04 GMTAmylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026 - Pluang
Fri, 07 Aug 2026 15:48:02 GMTAmylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore
Fri, 07 Aug 2026 15:28:15 GMTAmylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX) - Seeking Alpha
Fri, 07 Aug 2026 03:43:34 GMTAmylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Thu, 06 Aug 2026 23:20:04 GMTAmylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $26.7, Implies 22% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Amylyx Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.